Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cannabis Bioscience International Holdings Inc CBIH

Cannabis Bioscience International Holdings, Inc. is engaged in the provision of services in therapeutic areas of clinical research. The Company also operates a learning platform that provides knowledge and promotes professionalism in the cannabis industry through education and research about the medical properties and healing values of the plant. Through its Alpha Research Business, based in... see more

Recent & Breaking News (OTCPK:CBIH)

CBIH Unveils the Future of Wellness with Revolutionary Anti-Aging Chip

GlobeNewswire 3 days ago

CBIH Strengthens Clinical Research Team in Preparation for Launch of Next-Generation Cannabinoid Solutions

GlobeNewswire 10 days ago

Cannabis Bioscience International Holdings Selected to Participate in DEA Hearing on Cannabis Rescheduling Docket No. 1362 and Hearing Docket No. 24-44

GlobeNewswire November 12, 2024

CBIH Welcomes Charles Tamburello to Its Board, Strengthening M&A Strategy

Newsfile November 4, 2024

CBIH Strengthens Competitive Advantage with Rapid Expansion of Patent Filings

Newsfile October 28, 2024

CBIH Pursues Regulatory Compliance and Market Growth with Essential Licensing Applications

GlobeNewswire July 15, 2024

CBIH Charts Path to Future Leadership in Cannabis Medicine

GlobeNewswire July 8, 2024

CBIH: Unleashing the Potential of Cannabis for Tomorrow's Medicine

Newsfile July 8, 2024

CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers

GlobeNewswire July 1, 2024

CBIH Submits Groundbreaking Cannabis Patents for Breast and Pancreatic Cancer Treatments

Newsfile July 1, 2024

CBIH Announces Strategic Advancements Initiated by Recently Appointed Director, Setting a New Paradigm and Driving Visionary Change

GlobeNewswire June 26, 2024

CBIH's Recently Appointed Director Unveils Groundbreaking Product Strategies and Potential Partnership with Industry Leader

Newsfile June 24, 2024

Unleashing the Potential of Cannabis: Cannabis Bioscience International Holdings Reaches a Historic Valuation

GlobeNewswire June 17, 2024

CBIH Achieves $2 Billion Valuation Following StoneBridge Advisory Assessment

Newsfile June 17, 2024

CBIH and Vita Biotech Forge Alliance to Propel Clinical Studies Forward

GlobeNewswire June 5, 2024

Vita Biotech Retains CBIH Services for Clinical Studies

Newsfile June 5, 2024

Cannabis Bioscience International Holdings Engages StoneBridge Advisory for Comprehensive Company Valuation

Newsfile May 29, 2024

CBIH Engages Prestigious Law Firm for its First Patent Applications

Newsfile May 20, 2024

CBIH Welcomes New Treasurer and Director, Mr. John E. Jones

Newsfile May 6, 2024

CBIH Commences Clinical Trials of Osteoarthritis Injection "Orthocann"

Newsfile March 20, 2024